All of the following statements about Fanconi’s anemia are true, except –
## Core Concept
Fanconi's anemia is a rare, inherited disorder characterized by **bone marrow failure**, **congenital anomalies**, and a predisposition to **malignancies**, particularly **acute myeloid leukemia (AML)** and **other cancers**. It results from mutations in genes involved in **DNA repair mechanisms**, specifically **interstrand crosslink repair**.
## Why the Correct Answer is Right
The correct answer relates to the specifics of Fanconi's anemia, which involves impaired DNA repair, leading to chromosomal instability. This condition manifests with a classic triad of **aplastic anemia**, **leukemia**, and **congenital anomalies**. Understanding the underlying defect in DNA repair helps in identifying the correct statement that does not belong.
## Why Each Wrong Option is Incorrect
- **Option A:** Typically, Fanconi's anemia is associated with an increased risk of malignancies, particularly AML, making statements about cancer risk potentially true.
- **Option B:** Congenital anomalies are a hallmark of Fanconi's anemia, so statements regarding physical abnormalities are likely accurate.
- **Option C:** Aplastic anemia or bone marrow failure is a key feature, making statements about hematological manifestations likely correct.
- **Option D:** Without the specific details of each option, the focus is on understanding that Fanconi's anemia involves genetic instability, increased cancer risk, and specific physical and hematologic findings.
## Clinical Pearl / High-Yield Fact
A critical point to remember is that patients with Fanconi's anemia have a heightened sensitivity to **crosslinking agents** like **cisplatin** and **mitomycin C**, which can be used diagnostically. Clinically, this sensitivity can influence treatment choices, especially in cancer management.
## Correct Answer: D.